Building Medical Device Innovations Together
Client Ask: “We need help organizing our unpublished clinical data to prepare for commercialization.”
Client: Discectomy device manufacturer
Initial Service Areas Identified: Evidence services
Client Ask: “We need help organizing our unpublished clinical data to prepare for commercialization.”
Client: Discectomy device manufacturer
Initial Service Areas Identified: Evidence services
“Telos pulled us out of the fire a bunch of times. There were times that I called Telos and said that I need this and this by this date… and they would always deliver. Telos’ flexibility and their ability to hit deadlines to turn things around quickly was a game-changer. “
~ VP Market Access, Health Economics, & Reimbursement
Intrinsic Therapeutics: How We Partnered
Background
Back in 2017, Intrinsic Therapeutics was an innovative startup focused on a pivotal clinical trial and regulatory pathways. Intrinsic had no internal go-to-market staff.
Intrinsic had a wealth of unpublished clinical data from the largest randomized control trial ever performed on discectomy patients.
So how was Intrinsic going to leverage this data to prepare for commercialization?
Publication Challenge
Working with Telos, Intrinsic put together an aggressive publication strategy to factually and comprehensively communicate the value of the Barricaid Annular Closure Device.
Telos/Intrinsic designed the appropriate sub-studies, literature reviews, and analyses to objectively answer foreseeable stakeholder or decision-maker questions in the peer-reviewed literature and on the podium at a wide variety of spine and orthopedic society conferences.
Telos helped to move the total peer-reviewed article count from 14 to 53 in just over two years.
Reimbursement Challenge
Intrinsic was faced with the challenge that current reimbursement codes for discectomies do not involve an implant cost or the extra procedural time and steps required to implant the device.
Telos and Intrinsic laid out a plan for four separate health economics analyses based on 550 patients from the randomized controlled trial and brought all analyses to fruition:
- Socioeconomic impact (missed work and $ focus)
- Cost-effectiveness ($ / quality of life focus)
- 90-day direct costs ($ focus)
- Costs of second surgeries ($ focus)
Services Provided as a Result of Our Integrated Approach
- Evidence Services 100%
- Regulatory & Quality Services 70%
- Clinical Research Services 80%
Client Successes & Results of Partnering with Telos
- Helped to grow the total peer-reviewed article count from 14 to 53 in just over two years
- Prepared the Barricaid team to be able to objectively answer stakeholder and decision-maker questions backed by sub-studies, literature reviews, and analyses
- Created a comprehensive plan to address reimbursement code issues